Number |
32 |
21 |
|
Age (years) |
47.4 ± 16.6 |
51.1 ± 15.8 |
0.420*
|
Sex (Male/Female) |
14/18 |
9/12 |
0.949‡
|
Side (Right/Left) |
18/14 |
9/12 |
0.340‡
|
Diabetes mellitus (No/Yes) |
25/7 |
14/7 |
0.355‡
|
Dizziness (No/Yes) |
19/13 |
15/6 |
0.371‡
|
Tinnitus (No/Yes) |
6/26 |
2/19 |
0.455§
|
Ear fullness (No/Yes) |
14/18 |
12/9 |
0.340‡
|
Unaffected ear |
|
|
|
Initial PTA (4FA, dB HL) |
14.7 ± 8.0 |
16.3 ± 8.5 |
0.495*
|
Initial WRS (%) |
99.8 ± 1.4 |
99.0 ± 2.2 |
0.053†
|
ASSR (4FA, dB HL) |
25.5 ± 9.2 |
31.4 ± 11.1 |
0.063†
|
Affected ear |
|
|
|
Initial PTA (4FA, dB HL) |
66.6 ± 13.3 |
61.7 ± 14.6 |
0.216*
|
Initial WRS (%) |
32.8 ± 31.2 |
40.4 ± 31.8 |
0.326†
|
ASSR (4FA, dB HL) |
62.2 ± 15.2 |
73.2 ± 15.2 |
0.017† |
Steroid treatment (with ITD/ without ITD) |
15/17 |
7/14 |
0.328‡
|
Duration of follow-up (days) |
137 ± 195 |
122 ± 177 |
0.730†
|